Long-term toxicity and health-related quality of life after adjuvant chemoradiation therapy or radiation therapy alone for high-risk endometrial cancer in the randomized PORTEC-3 trial - Post, CCB; de Boer, SM; Powell, SE (Int J Radiat Oncol Biol Phys, 2021)
et al.